Zealand says Roche obesity drug cut weight up to 9.2%
Zealand Pharma said its experimental obesity drug developed with Roche helped patients lose up to 9.2% of body weight in a mid-stage trial for people with overweight/obesity and type 2 diabetes.
Zealand Pharma said its experimental obesity drug developed with Roche helped patients lose up to 9.2% of body weight in a mid-stage trial for people with overweight/obesity and type 2 diabetes.